Format

Send to

Choose Destination
Mol Ther. 2016 Nov;24(11):1889-1891. doi: 10.1038/mt.2016.192.

Prevention of Muscle Wasting by CRISPR/Cas9-mediated Disruption of Myostatin In Vivo.

Author information

1
CAS Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; University of Chinese Academy of Sciences, Shanghai, P.R. China.
2
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P.R. China.
3
Hanbio Research Center, Hanbio Co. Ltd., Shanghai, P.R. China.
4
CAS Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; University of Chinese Academy of Sciences, Shanghai, P.R. China.
5
Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
6
CAS Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; University of Chinese Academy of Sciences, Shanghai, P.R. China. Electronic address: qrding@sibs.ac.cn.
PMID:
27916995
PMCID:
PMC5154488
DOI:
10.1038/mt.2016.192
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center